AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations ...
Discover how Monte Carlo analysis helps investors assess risk and make informed decisions. Explore its role in generating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results